Key result
Non-HDL-C below 4.43 mmol/L is linked to ~35% higher NAFLD prevalence per unit increase.
Why the study?
Is non-HDL-C associated with the prevalence of NAFLD in adults?
Observational (n=79,961)
Is non-HDL-C associated with the prevalence of NAFLD in adults?
Odds Ratio: 1.35 (95% CI 1.32–1.37)
p-value: p=<.0001
There is a non-linear association between non-HDL-C and NAFLD prevalence, with increased risk observed only at levels below 4.43 mmol/L.
Dyslipidemia negatively impacts the development of nonalcoholic fatty liver disease (NAFLD); yet, the specific relationship between non-high-density lipoprotein cholesterol (non-HDL-C) and NAFLD has not been previously examined. This study aims to explore the association between levels of non-HDL-C and the prevalence of NAFLD in adults residing in Western China. We used data from the Xinjiang physical examination program in 2023, which included a total of 186,965 adults in Kumul District. A variety of statistical techniques were applied, including threshold effect analysis, subgroup analysis, smooth curve fitting, and multivariate logistic regression, to clarify the relationship between non-HDL-C and NAFLD. Of the 79,961 participants, the mean age was 57.21 ± 13.08 years, and the mean non-HDL-C was 3.47 ± 1.10 mmol/L. Smooth curve fitting revealed a non-linear relationship between non-HDL-C and NAFLD, with a significant threshold effect at 4.43 mmol/L ( P for likelihood ratio test < .001). Below this inflection point, each unit increase in non-HDL-C was associated with a 35% higher prevalence of NAFLD (OR = 1.35; 95% confidence interval (CI): 1.32–1.37; P < .0001), whereas no significant association was observed above this threshold (OR = 0.98; 95% CI: 0.95–1.02; P = .3830). Conventional quartile-based analyses also showed a positive trend (Q4 OR = 1.90; 95% CI: 1.81–1.98), but these findings need to be interpreted with caution, given the non-linear nature of the underlying relationship. Interaction tests showed that the non-HDL-C–NAFLD association remained significant across most subgroups, with notable interactions observed for body mass index, education, exercise, and hypertension. Our findings suggest a non-linear association between non-HDL-C and NAFLD, with a threshold at around 4.43 mmol/L. Below this level, higher non-HDL-C was linked to increased NAFLD risk, but above it, the association leveled off. This suggests that threshold-based approaches may better capture the true relationship than simple linear models. Further large-scale prospective studies are still needed to confirm these findings.
No takes yet. Share an insight, caveat, or question.
Ma et al. (2026) conducted an observational in Nonalcoholic fatty liver disease (NAFLD) (n=79,961). Non-high-density lipoprotein cholesterol (non-HDL-C) vs. Lower non-HDL-C levels was evaluated on Prevalence of NAFLD (OR 1.35, 95% CI 1.32-1.37, p=<.0001). Non-HDL-C levels below 4.43 mmol/L were associated with a 35% higher prevalence of NAFLD per unit increase (OR 1.35; 95% CI 1.32-1.37; P<.0001), with no significant association above this threshold.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: